TP53 and cancer: In summary, this study demonstrates that a novel pathway, involving transcriptional repression of TP53INP1, reduction in p53 protein phosphorylation at Ser-46 and consequent p53 protein inactivation, contributes to N-Myc and HDAC2-mediated cancer cell survival.